Galantamine Hydrobromide
Overview
Galantamine Hydrobromide is an alkaloid used for the treatment of mild to moderate Alzheimer's disease and various memory impairments. It functions as a reversible competitive inhibitor of acetylcholinesterase, enhancing acetylcholine availability in the brain.
API suppliers (7)
Suppliers of Galantamine Hydrobromide evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.
Country recorded for 4 of 7 suppliers.
4 of 7 hold a GMP certificate on record in the EU or UK registers
- JUBILANT BIOSYS LTDIndia1 active DMF
- SANOCHEMIA PHARMAZEUTIKA AGAustria1 active DMF GMP on record
- DR REDDYS LABORATORIES LTD1 active DMF GMP on record
- WUHAN SHIJI PHARMACEUTICAL CO LTD
- SA AJINOMOTO OMNICHEM NVBelgium
- MACFARLAN SMITH LTD GMP on record
- Janssen Pharmaceutica NVBelgium GMP on record
Therapeutic areas
Do you supply Galantamine Hydrobromide? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.